My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    1.

    Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

    Calza S, Hall P, Auer G, Bjöhle J, Klaar S, Kronenwett U, Liu ET, Miller L, Ploner A, Smeds J, Bergh J, Pawitan Y.

    Breast Cancer Res. 2006;8(4):R34.PMID: 16846532 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.

    Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, He X, Palazzo JP, Olopade OI, Szabo A, Perou CM, Bernard PS.

    Breast Cancer Res. 2006;8(2):R23. Epub 2006 Apr 20.PMID: 16626501 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

    Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

    J Surg Res. 2007 Nov;143(1):109-18.PMID: 17950079 [PubMed - indexed for MEDLINE]Related articles

    4.

    Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

    Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY.

    Breast Cancer Res Treat. 2006 Feb;95(3):243-55. Epub 2005 Oct 27.PMID: 16261404 [PubMed - indexed for MEDLINE]Related articles

    5.

    Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

    Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

    BMC Genomics. 2006 May 26;7:127.PMID: 16729877 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

    Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, Shaw PM, Smeds J, Skoog L, Wedrén S, Bergh J.

    Breast Cancer Res. 2005;7(6):R953-64. Epub 2005 Oct 3.PMID: 16280042 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.

    Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

    Ann Surg Oncol. 2007 Oct;14(10):2994-3003. Epub 2007 Jul 24.PMID: 17647064 [PubMed - indexed for MEDLINE]Related articles

    8.

    Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

    Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.

    PLoS One. 2009 Jul 3;4(7):e6146.PMID: 19582160 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

    BMC Cancer. 2007 Apr 12;7:63.PMID: 17430582 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.

    Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS.

    Breast Cancer Res. 2007;9(3):R30.PMID: 17504517 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.

    Habermann JK, Doering J, Hautaniemi S, Roblick UJ, Bündgen NK, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu RK, Ma Y, Krüger S, Bruch HP, Auer G, Guo NL, Ried T.

    Int J Cancer. 2009 Apr 1;124(7):1552-64.PMID: 19101988 [PubMed - indexed for MEDLINE]Related articles

    13.

    Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

    Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

    J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.PMID: 18037662 [PubMed - indexed for MEDLINE]Related articles

    14.

    Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.

    Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D.

    Breast Cancer Res. 2009;11(2):R23. Epub 2009 Apr 30.PMID: 19405945 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Discovery and validation of breast cancer subtypes.

    Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R.

    BMC Genomics. 2006 Sep 11;7:231. Erratum in: BMC Genomics. 2007 Apr 13;8(1):101. PMID: 16965636 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

    Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

    Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.PMID: 18662380 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Gene expression patterns associated with p53 status in breast cancer.

    Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS, Perou CM.

    BMC Cancer. 2006 Dec 6;6:276.PMID: 17150101 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.

    Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM.

    Clin Cancer Res. 2007 Apr 15;13(8):2329-34.PMID: 17438091 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial.

    Rody A, Karn T, Solbach C, Gaetje R, Munnes M, Kissler S, Ruckhäberle E, Minckwitz GV, Loibl S, Holtrich U, Kaufmann M.

    Breast. 2007 Jun;16(3):235-40. Epub 2007 Apr 20.PMID: 17449250 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes]

    Zhang HM, Zhang BN, Xuan LX, Zhao P.

    Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):447-51. Chinese. PMID: 19950556 [PubMed - in process]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk